December 17th, 2024: Danish studies link Ozempic to doubled risk of rare vision loss condition Novo Nordisks Ozempic is facing scrutiny after two Danish studies found a potential link between the diabetes drug and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing vision loss due to reduced blood flow to the optic nerve
In animal studies, SGLT2 inhibitors do not cause developmental toxicity during organogenesis in the first trimester
While many studies have described the advantages of cells derived from these organs, their advantage as a source of younger cells has not been sufficiently covered by the literature
The FDA has placed MOTS-C in Category 2 of bulk drug substances for compounding, meaning there are noted safety risks that warrant restricted access
Storage Instructions: Store lyophilized vials at 28C, protected from light, in the original packaging
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats
